» Articles » PMID: 33753887

ω-3PUFA Supplementation Ameliorates Adipose Tissue Inflammation and Insulin-stimulated Glucose Disposal in Subjects with Obesity: a Potential Role for Apolipoprotein E

Overview
Specialty Endocrinology
Date 2021 Mar 23
PMID 33753887
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Long chain omega-3 polyunsaturated fatty acids (ω-3PUFA) supplementation in animal models of diet-induced obesity has consistently shown to improve insulin sensitivity. The same is not always reported in human studies with insulin resistant (IR) subjects with obesity.

Objective: We studied whether high-dose ω-3PUFA supplementation for 3 months improves insulin sensitivity and adipose tissue (AT) inflammation in IR subjects with obesity.

Methods: Thirteen subjects (BMI = 39.3 ± 1.6 kg/m) underwent 80 mU/m·min euglycemic-hyperinsulinemic clamp with subcutaneous (Sc) AT biopsy before and after 3 months of ω-3PUFA (DHA and EPA, 4 g/daily) supplementation. Cytoadipokine plasma profiles were assessed before and after ω-3PUFA. AT-specific inflammatory gene expression was evaluated on Sc fat biopsies. Microarray analysis was performed on the fat biopsies collected during the program.

Results: Palmitic and stearic acid plasma levels were significantly reduced (P < 0.05) after ω-3PUFA. Gene expression of pro-inflammatory markers and adipokines were improved after ω-3PUFA (P < 0.05). Systemic inflammation was decreased after ω-3PUFA, as shown by cytokine assessment (P < 0.05). These changes were associated with a 25% increase in insulin-stimulated glucose disposal (4.7 ± 0.6 mg/kg ffm•min vs. 5.9 ± 0.9 mg/kg ffm•min) despite no change in body weight. Microarray analysis identified 53 probe sets significantly altered post- ω-3PUFA, with Apolipoprotein E (APOE) being one of the most upregulated genes.

Conclusion: High dose of long chain ω-3PUFA supplementation modulates significant changes in plasma fatty acid profile, AT, and systemic inflammation. These findings are associated with significant improvement of insulin-stimulated glucose disposal. Unbiased microarray analysis of Sc fat biopsy identified APOE as among the most differentially regulated gene after ω-3PUFA supplementation. We speculate that ω-3PUFA increases macrophage-derived APOE mRNA levels with anti-inflammatory properties.

Citing Articles

The Role of Unsaturated Fatty Acid-Rich Dairy Products in Adipocyte Metabolism.

Machado M, Costa E, Silva S, Gomes A, Pintado M Molecules. 2024; 29(23).

PMID: 39683663 PMC: 11643689. DOI: 10.3390/molecules29235502.


Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance.

Hernandez J, Li T, Ghannam H, Rau C, Masuda M, Madura 2nd J JCI Insight. 2024; 9(3).

PMID: 38206766 PMC: 10967463. DOI: 10.1172/jci.insight.170772.


Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review.

Sandoval C, Nahuelqueo K, Mella L, Recabarren B, Souza-Mello V, Farias J Front Nutr. 2023; 10:1288804.

PMID: 38024342 PMC: 10665854. DOI: 10.3389/fnut.2023.1288804.


Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients.

Wu S, Chen W, Chang J, Guu T, Hsin M, Huang C J Pers Med. 2023; 13(6).

PMID: 37373992 PMC: 10300918. DOI: 10.3390/jpm13061003.


A Randomized Trial of the Effects of Dietary n3-PUFAs on Skeletal Muscle Function and Acute Exercise Response in Healthy Older Adults.

Kunz H, Michie K, Gries K, Zhang X, Ryan Z, Lanza I Nutrients. 2022; 14(17).

PMID: 36079794 PMC: 9459748. DOI: 10.3390/nu14173537.


References
1.
James W . Obesity: A Global Public Health Challenge. Clin Chem. 2018; 64(1):24-29. DOI: 10.1373/clinchem.2017.273052. View

2.
Ferrante Jr A . Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med. 2007; 262(4):408-14. DOI: 10.1111/j.1365-2796.2007.01852.x. View

3.
Gregor M, Hotamisligil G . Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011; 29:415-45. DOI: 10.1146/annurev-immunol-031210-101322. View

4.
Van Gaal L, Mertens I, De Block C . Mechanisms linking obesity with cardiovascular disease. Nature. 2006; 444(7121):875-80. DOI: 10.1038/nature05487. View

5.
Yazici D, Sezer H . Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol. 2017; 960:277-304. DOI: 10.1007/978-3-319-48382-5_12. View